130 related articles for article (PubMed ID: 5337023)
1. Ultrastructural pancreatic beta-cell changes in rabbits after small and large doses of alloxan.
Wellmann KF; Volk BW; Lazarus SS
Diabetes; 1967 Apr; 16(4):242-51. PubMed ID: 5337023
[No Abstract] [Full Text] [Related]
2. STUDIES ON A LATENT DIABETIC STATE IN CORTISONE-ALLOXAN TREATED RABBITS.
LAZARUS SS; VOLK BW
Diabetes; 1964; 13():54-9. PubMed ID: 14104176
[No Abstract] [Full Text] [Related]
3. Alloxan effects on blood glucose level and pancreatic islet tissue in Lampetra fluviatilis.
Biuw LW
Gen Comp Endocrinol; 1970 Aug; 15(1):43-51. PubMed ID: 4917483
[No Abstract] [Full Text] [Related]
4. FINE STRUCTURE OF RABBIT PANCREATIC B CELLS IN CORTISONE-ALLOXAN INDUCED SUBDIABETES.
VOLK BW; WELLMANN KF; LAZARUS SS
Lab Invest; 1965 Jul; 14():1375-91. PubMed ID: 14327239
[No Abstract] [Full Text] [Related]
5. Pancreatic B cell morphology and insulin content of normal and alloxan-diabetic rabbits and their offspring.
Wellmann KF; Volk BW; Lazarus SS; Brancato P
Diabetes; 1969 Mar; 18(3):138-45. PubMed ID: 4885547
[No Abstract] [Full Text] [Related]
6. Effect of electromagnetic radiation modulated by biostructures on the course of alloxan-induced diabetes mellitus in rats.
Garyaev PP; Kokaya AA; Mukhina IV; Leonova-Garyaeva EA; Kokaya NG
Bull Exp Biol Med; 2007 Feb; 143(2):197-9. PubMed ID: 17970200
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural alterations in the pancreatic B-cells of the newt (Triturus vulgaris) induced by alloxan.
Trandaburu T; Ionescu M
Acta Anat (Basel); 1971; 79(2):257-69. PubMed ID: 4939836
[No Abstract] [Full Text] [Related]
8. Long-term effects of alloxan in mice.
Ahrén B; Sundkvist G
Int J Pancreatol; 1995 Apr; 17(2):197-201. PubMed ID: 7622942
[TBL] [Abstract][Full Text] [Related]
9. [Electron-microscopic studies on the acino-insulous areas in the pancreas of normal and alloxan diabetic rats].
Faller A
Verh Anat Ges; 1966; 61():113-25. PubMed ID: 4878013
[No Abstract] [Full Text] [Related]
10. Silymarin induces recovery of pancreatic function after alloxan damage in rats.
Soto C; Mena R; Luna J; Cerbón M; Larrieta E; Vital P; Uría E; Sánchez M; Recoba R; Barrón H; Favari L; Lara A
Life Sci; 2004 Sep; 75(18):2167-80. PubMed ID: 15325843
[TBL] [Abstract][Full Text] [Related]
11. Beta cell structure in latent and chronic diabetes of the rabbit.
Volk BW; Lazarus SS; Wellman KF
Diabetes; 1965 Dec; 14(12):792-804. PubMed ID: 5321764
[No Abstract] [Full Text] [Related]
12. Modification of streptozotocin-induced diabetes in rats by pretreatment with cortisone.
Wellmann KF; Volk BW
Diabetologia; 1977 Aug; 13(4):331-7. PubMed ID: 144079
[TBL] [Abstract][Full Text] [Related]
13. Variations of susceptibility to alloxan induced diabetes in the rabbit.
Zhao ZH; Watschinger B; Brown CD; Beyer MM; Friedman EA
Horm Metab Res; 1987 Nov; 19(11):534-7. PubMed ID: 3428871
[TBL] [Abstract][Full Text] [Related]
14. Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57Bl6/J mice treated with alloxan.
Rooman I; Bouwens L
Diabetologia; 2004 Feb; 47(2):259-65. PubMed ID: 14666367
[TBL] [Abstract][Full Text] [Related]
15. Hydropic changes in pancreatic ductules and islets in alloxan diabetes in the rabbit.
DUFF GL; McMILLAN GC; WILSON DC
Proc Soc Exp Biol Med; 1947 Feb; 64(2):251-5. PubMed ID: 20287392
[No Abstract] [Full Text] [Related]
16. Influence of alloxan administration on the blood glucose, islets of langerhans and some other tissues of the frog, Rana tigrina.
Kumar S; Khanna SS
Anat Anz; 1978; 143(3):242-9. PubMed ID: 356673
[TBL] [Abstract][Full Text] [Related]
17. Hepatic and pancreatic effects of polyenoylphosphatidylcholine in rats with alloxan-induced diabetes.
Buko V; Lukivskaya O; Nikitin V; Tarasov Y; Zavodnik L; Borodinsky A; Gorenshtein B; Janz B; Gundermann KJ; Schumacher R
Cell Biochem Funct; 1996 Jun; 14(2):131-7. PubMed ID: 8640953
[TBL] [Abstract][Full Text] [Related]
18. Chemically induced (streptozotocin-alloxan) diabetes mellitus in the dog. Biochemical and ultrastructural studies.
Black HE; Rosenblum IY; Capen CC
Am J Pathol; 1980 Feb; 98(2):295-310. PubMed ID: 6444498
[TBL] [Abstract][Full Text] [Related]
19. Administration of NF-kappaB decoy inhibits pancreatic activation of NF-kappaB and prevents diabetogenesis by alloxan in mice.
Quan N; Ho E; La W; Tsai YH; Bray T
FASEB J; 2001 Jul; 15(9):1616-8. PubMed ID: 11427504
[No Abstract] [Full Text] [Related]
20. Tissue-specific reduction of galanin content in the pancreas in alloxan diabetes in the mouse.
Dunning BE; Ahrén B
Acta Physiol Scand; 1993 Oct; 149(2):215-9. PubMed ID: 7505518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
